Skip to main content
Erschienen in: Psychiatric Quarterly 3/2016

24.11.2015 | Original Paper

Cognitive Impairment in Schizophrenia: Interplay of BDNF and Childhood Trauma? A Review of Literature

verfasst von: Geetanjali Sahu, Kishor Malavade, Theresa Jacob

Erschienen in: Psychiatric Quarterly | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Cognitive impairment is a core feature of schizophrenia. These deficits can also serve as an endophenotype for the illness in genetic studies. There is evidence that suggests that cognition can be considered a reasonable target for intervention in both schizophrenia and bipolar disorder. One of the most studied genetic phenotypes for psychosis is brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms. BDNF has an established role in neuronal development and cell survival in response to stress and is abnormally expressed in schizophrenia. Studies have shown that childhood trauma is associated with poor prognosis of schizophrenic patients. BDNF-Val66Met polymorphism has been shown to moderate the impact of childhood adversity on later expression of affective symptoms, suggesting the possibility of gene environment interactions. Considering the recent advances of neuroscience an up to date review of relevant literature is warranted in this field. This article reviews the current literature available regarding associations between the Val66Met polymorphism, childhood trauma and cognitive dysfunction in schizophrenia.
Literatur
1.
Zurück zum Zitat Green MF: What are the functional consequences of neurocognitive deficits in schizophrenia? The American Journal of Psychiatry 153(3):321–330, 1996.CrossRefPubMed Green MF: What are the functional consequences of neurocognitive deficits in schizophrenia? The American Journal of Psychiatry 153(3):321–330, 1996.CrossRefPubMed
2.
Zurück zum Zitat Green MF, Kern RS, Braff DL, Mintz J: Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the “right stuff? Schizophrenia Bulletin 26:119–136, 2000.CrossRefPubMed Green MF, Kern RS, Braff DL, Mintz J: Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the “right stuff? Schizophrenia Bulletin 26:119–136, 2000.CrossRefPubMed
3.
Zurück zum Zitat Green MF, Kern RS, Heaton RK: Longitudinal studies of cognition and functional outcome in schizophrenia: Implications for MATRICS. Schizophrenia Research 72:41–51, 2004.CrossRefPubMed Green MF, Kern RS, Heaton RK: Longitudinal studies of cognition and functional outcome in schizophrenia: Implications for MATRICS. Schizophrenia Research 72:41–51, 2004.CrossRefPubMed
4.
Zurück zum Zitat Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK: Identification of separable cognitive factors in schizophrenia. Schizophrenia Research 72:29–39, 2004.CrossRefPubMed Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK: Identification of separable cognitive factors in schizophrenia. Schizophrenia Research 72:29–39, 2004.CrossRefPubMed
5.
Zurück zum Zitat Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano G, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE, Hsiao JK, Lieberman JA: Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Archives of General Psychiatry 64(6):633–647, 2007a.CrossRefPubMed Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano G, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE, Hsiao JK, Lieberman JA: Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Archives of General Psychiatry 64(6):633–647, 2007a.CrossRefPubMed
6.
Zurück zum Zitat Keefe RS, Sweeney JA, Gu H, Hamer RM, Perkins DO, McEvoy JP, Lieberman JA: Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: A randomized, double-blind 52-week comparison. The American Journal of Psychiatry 164(7):1061–1071, 2007b.CrossRefPubMed Keefe RS, Sweeney JA, Gu H, Hamer RM, Perkins DO, McEvoy JP, Lieberman JA: Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: A randomized, double-blind 52-week comparison. The American Journal of Psychiatry 164(7):1061–1071, 2007b.CrossRefPubMed
7.
Zurück zum Zitat Carrion RE, Goldberg TE, McLaughlin D, Auther AM, Correll CU, Cornblatt BA: Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis. American Journal of Psychiatry 168(8):806–813, 2011.CrossRefPubMedPubMedCentral Carrion RE, Goldberg TE, McLaughlin D, Auther AM, Correll CU, Cornblatt BA: Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis. American Journal of Psychiatry 168(8):806–813, 2011.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Horan WP, Green MF, DeGroot M, Fiske A, Hellemann G, Kee K, Kern RS, Lee J, Sergi MJ, Subotnik KL, Sugar CA, Ventura J, Nuechterlein KH: Social cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patients. Schizophrenia Bulletin 38(4):865–872, 2012.CrossRefPubMed Horan WP, Green MF, DeGroot M, Fiske A, Hellemann G, Kee K, Kern RS, Lee J, Sergi MJ, Subotnik KL, Sugar CA, Ventura J, Nuechterlein KH: Social cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patients. Schizophrenia Bulletin 38(4):865–872, 2012.CrossRefPubMed
9.
Zurück zum Zitat Bayer TA, Falkai P, Maier W: Genetic and non-genetic vulnerability factors in schizophrenia: The basis of the “two hit hypothesis”. Journal of Psychiatric Research 33(6):543–548, 1999.CrossRefPubMed Bayer TA, Falkai P, Maier W: Genetic and non-genetic vulnerability factors in schizophrenia: The basis of the “two hit hypothesis”. Journal of Psychiatric Research 33(6):543–548, 1999.CrossRefPubMed
10.
Zurück zum Zitat Caspi A, Moffitt TE: Gene-environment interactions in psychiatry: Joining forces with neuroscience. Nature Reviews Neuroscience 7(7):583–590, 2006.CrossRefPubMed Caspi A, Moffitt TE: Gene-environment interactions in psychiatry: Joining forces with neuroscience. Nature Reviews Neuroscience 7(7):583–590, 2006.CrossRefPubMed
11.
Zurück zum Zitat Braff DL, Freedman R, Schork NJ, Gottesman II: Deconstructing schizophrenia: An overview of the use of endophenotypes in order to understand a complex disorder. Schizophrenia Bulletin 33(1):21–32, 2007.CrossRefPubMed Braff DL, Freedman R, Schork NJ, Gottesman II: Deconstructing schizophrenia: An overview of the use of endophenotypes in order to understand a complex disorder. Schizophrenia Bulletin 33(1):21–32, 2007.CrossRefPubMed
12.
Zurück zum Zitat Burdick KE, Goldberg JF, Harrow M, Faull RN, Malhotra AK: Neurocognition as a stable endophenotype in bipolar disorder and schizophrenia. The Journal of Nervous and Mental Disease 194(4):255–260, 2006.CrossRefPubMed Burdick KE, Goldberg JF, Harrow M, Faull RN, Malhotra AK: Neurocognition as a stable endophenotype in bipolar disorder and schizophrenia. The Journal of Nervous and Mental Disease 194(4):255–260, 2006.CrossRefPubMed
13.
Zurück zum Zitat Gur RE, Calkins ME, Gur RC, Horan WP, Nuechterlein KH, Seidman LJ, Stone WS: The consortium on the genetics of schizophrenia: Neurocognitive endophenotypes. Schizophrenia Bulletin 33(1):49–68, 2007.CrossRefPubMed Gur RE, Calkins ME, Gur RC, Horan WP, Nuechterlein KH, Seidman LJ, Stone WS: The consortium on the genetics of schizophrenia: Neurocognitive endophenotypes. Schizophrenia Bulletin 33(1):49–68, 2007.CrossRefPubMed
14.
Zurück zum Zitat Burdick KE, Ketter TA, Goldberg JF, Calabrese JR: Assessing cognitive function in bipolar disorder: Challenges and recommendations for clinical trial design. The Journal of Clinical Psychiatry 76(3):e342–e350, 2015.CrossRefPubMedPubMedCentral Burdick KE, Ketter TA, Goldberg JF, Calabrese JR: Assessing cognitive function in bipolar disorder: Challenges and recommendations for clinical trial design. The Journal of Clinical Psychiatry 76(3):e342–e350, 2015.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Phelps EA: Emotion and cognition: Insights from studies of the human amygdala. Annual Review of Psychology 57:27–53, 2006.CrossRefPubMed Phelps EA: Emotion and cognition: Insights from studies of the human amygdala. Annual Review of Psychology 57:27–53, 2006.CrossRefPubMed
16.
Zurück zum Zitat Gorman JM, Kent JM, Sullivan GM, Coplan JD: Neuroanatomical hypothesis of panic disorder, revised. The American Journal of Psychiatry 157(4):493–505, 2000.CrossRefPubMed Gorman JM, Kent JM, Sullivan GM, Coplan JD: Neuroanatomical hypothesis of panic disorder, revised. The American Journal of Psychiatry 157(4):493–505, 2000.CrossRefPubMed
17.
Zurück zum Zitat Desmedt A, Marighetto A, Richter-Levin G, Calandreau L: Adaptive emotional memory: The key hippocampal-amygdalar interaction. Stress 11:1–12, 2015. Desmedt A, Marighetto A, Richter-Levin G, Calandreau L: Adaptive emotional memory: The key hippocampal-amygdalar interaction. Stress 11:1–12, 2015.
18.
19.
Zurück zum Zitat Hornig T, Valerius T, Feige B, Bubl E, Olbrich HM, Van-Elst LT: Neuropsychological and cerebral morphometric aspects of negative symptoms in schizophrenia: Negative symptomatology is associated with specific mnestic deficits in schizophrenic patients. BMC Psychiatry 14:326, 2014.CrossRefPubMedPubMedCentral Hornig T, Valerius T, Feige B, Bubl E, Olbrich HM, Van-Elst LT: Neuropsychological and cerebral morphometric aspects of negative symptoms in schizophrenia: Negative symptomatology is associated with specific mnestic deficits in schizophrenic patients. BMC Psychiatry 14:326, 2014.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Niitsu T, Ishima T, Yoshida T, Hashimoto T, Matsuzawa D, Shirayama Y, Nakazato M, Shimizu E, Hashimoto K, Iyo M: A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophrenia. Psychiatry Research 215(2):268–273, 2014.CrossRefPubMed Niitsu T, Ishima T, Yoshida T, Hashimoto T, Matsuzawa D, Shirayama Y, Nakazato M, Shimizu E, Hashimoto K, Iyo M: A positive correlation between serum levels of mature brain-derived neurotrophic factor and negative symptoms in schizophrenia. Psychiatry Research 215(2):268–273, 2014.CrossRefPubMed
21.
Zurück zum Zitat Numata S, Ueno S, Iga J, Yamauchi K, Hongwei S, Ohta K, Kinouchi S, Shibuya-Tayoshi S, Tayoshi S, Aono M, Kameoka N, Sumitani S, Tomotake M, Kaneda Y, Taniguchi T, Ishimoto Y, Ohmori T: Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neuroscience Letters 401(1–2):1–5, 2006.CrossRefPubMed Numata S, Ueno S, Iga J, Yamauchi K, Hongwei S, Ohta K, Kinouchi S, Shibuya-Tayoshi S, Tayoshi S, Aono M, Kameoka N, Sumitani S, Tomotake M, Kaneda Y, Taniguchi T, Ishimoto Y, Ohmori T: Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neuroscience Letters 401(1–2):1–5, 2006.CrossRefPubMed
22.
Zurück zum Zitat Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ: Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37(12):1553–1561, 1998.CrossRefPubMed Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ: Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37(12):1553–1561, 1998.CrossRefPubMed
23.
Zurück zum Zitat Fernandes BS, Berk M, Turck CW, Steiner J, Gonçalves CA: Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: A comparative meta-analysis. Molecular Psychiatry 19(7):750–751, 2014.CrossRefPubMed Fernandes BS, Berk M, Turck CW, Steiner J, Gonçalves CA: Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: A comparative meta-analysis. Molecular Psychiatry 19(7):750–751, 2014.CrossRefPubMed
24.
Zurück zum Zitat Harrisberger F, Smieskova R, Schmidt A, Lenz C, Walter A, Wittfeld K, Grabe HJ, Lang UE, Fusar-Poli P, Borgwardt S: BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews 55:107–118, 2015.CrossRef Harrisberger F, Smieskova R, Schmidt A, Lenz C, Walter A, Wittfeld K, Grabe HJ, Lang UE, Fusar-Poli P, Borgwardt S: BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews 55:107–118, 2015.CrossRef
25.
Zurück zum Zitat Cheeran B, Talelli P, Mori F, Koch G, Suppa A, Edwards M, Houlden H, Bhatia K, Greenwood R, Rothwell JC: A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. The Journal of Physiology 586(Pt 23):5717–5725, 2008.CrossRefPubMedPubMedCentral Cheeran B, Talelli P, Mori F, Koch G, Suppa A, Edwards M, Houlden H, Bhatia K, Greenwood R, Rothwell JC: A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. The Journal of Physiology 586(Pt 23):5717–5725, 2008.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Tamminga CA, Stan AD, Wagner AD: The hippocampal formation in schizophrenia. American Journal of Psychiatry 167(10):1178–1193, 2010.CrossRefPubMed Tamminga CA, Stan AD, Wagner AD: The hippocampal formation in schizophrenia. American Journal of Psychiatry 167(10):1178–1193, 2010.CrossRefPubMed
27.
Zurück zum Zitat Boyer P, Phillips JL, Rousseau FL, Ilivitsky S: Hippocampal abnormalities and memory deficits: New evidence of a strong pathophysiological link in schizophrenia. Brain Research Reviews 54(1):92–112, 2007.CrossRefPubMed Boyer P, Phillips JL, Rousseau FL, Ilivitsky S: Hippocampal abnormalities and memory deficits: New evidence of a strong pathophysiological link in schizophrenia. Brain Research Reviews 54(1):92–112, 2007.CrossRefPubMed
28.
Zurück zum Zitat Konradi C, Yang CK, Zimmerman EI, Lohmann KM, Gresch P, Pantazopoulos H, Berretta S, Heckers S: Hippocampal interneurons are abnormal in schizophrenia. Schizophrenia Research 131(1–3):165–73, 2011.CrossRefPubMedPubMedCentral Konradi C, Yang CK, Zimmerman EI, Lohmann KM, Gresch P, Pantazopoulos H, Berretta S, Heckers S: Hippocampal interneurons are abnormal in schizophrenia. Schizophrenia Research 131(1–3):165–73, 2011.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Shenton ME, Gerig G, McCarley RW, Szekely G, Kikinis R: Amygdala hippocampal shape differences in schizophrenia: The application of 3D shape models to volumetric MR data. Psychiatry Research 115(1–2):15–35, 2002.CrossRefPubMedPubMedCentral Shenton ME, Gerig G, McCarley RW, Szekely G, Kikinis R: Amygdala hippocampal shape differences in schizophrenia: The application of 3D shape models to volumetric MR data. Psychiatry Research 115(1–2):15–35, 2002.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Nelson MD, Saykin AJ, Flashman LA, Riordan HJ: Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: A metaanalytic study. Archives of General Psychiatry 55(5):433–440, 1998.CrossRefPubMed Nelson MD, Saykin AJ, Flashman LA, Riordan HJ: Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: A metaanalytic study. Archives of General Psychiatry 55(5):433–440, 1998.CrossRefPubMed
31.
Zurück zum Zitat Adriano F, Caltagirone C, Spalletta G: Hippocampal volume reduction in first-episode and chronic schizophrenia: A review and meta-analysis. The Neuroscientist 18(2):180–200, 2012.CrossRefPubMed Adriano F, Caltagirone C, Spalletta G: Hippocampal volume reduction in first-episode and chronic schizophrenia: A review and meta-analysis. The Neuroscientist 18(2):180–200, 2012.CrossRefPubMed
32.
Zurück zum Zitat Schäfer I, Fisher HL: Childhood trauma and psychosis—What is the evidence? Dialogues in Clinical Neuroscience 13(3):360–365, 2011.PubMedPubMedCentral Schäfer I, Fisher HL: Childhood trauma and psychosis—What is the evidence? Dialogues in Clinical Neuroscience 13(3):360–365, 2011.PubMedPubMedCentral
33.
Zurück zum Zitat Várese F, Smeets F, Drukker M, Lieverse R, Lataster T, Viechtbauer W, Read J, van Os J, Bentall RP: Childhood adversities increase the risk of psychosis: A meta-analysis of patient-control, prospective and cross-sectional cohort studies. Schizophrenia Bulletin 38(4):661–671, 2012.CrossRefPubMedPubMedCentral Várese F, Smeets F, Drukker M, Lieverse R, Lataster T, Viechtbauer W, Read J, van Os J, Bentall RP: Childhood adversities increase the risk of psychosis: A meta-analysis of patient-control, prospective and cross-sectional cohort studies. Schizophrenia Bulletin 38(4):661–671, 2012.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Trotta A, Di Forti M, Mondelli V, Dazzan P, Pariante C, David A, Mulè A, Ferraro L, Formica I, Murray RM, Fisher HL: Prevalence of bullying victimisation amongst first-episode psychosis patients and unaffected controls. Schizophrenia Research 150(1):169–175, 2013.CrossRefPubMed Trotta A, Di Forti M, Mondelli V, Dazzan P, Pariante C, David A, Mulè A, Ferraro L, Formica I, Murray RM, Fisher HL: Prevalence of bullying victimisation amongst first-episode psychosis patients and unaffected controls. Schizophrenia Research 150(1):169–175, 2013.CrossRefPubMed
35.
Zurück zum Zitat van Winkel R, van Nierop M, Myin-Germeys I, van Os J: Childhood trauma as a cause of psychosis: Linking genes, psychology, and biology. Canadian Journal of Psychiatry 58(1):44–51, 2013.PubMed van Winkel R, van Nierop M, Myin-Germeys I, van Os J: Childhood trauma as a cause of psychosis: Linking genes, psychology, and biology. Canadian Journal of Psychiatry 58(1):44–51, 2013.PubMed
36.
Zurück zum Zitat Aas M, Navari S, Gibbs A, Mondelli V, Fisher HL, Morgan C, Morgan K, MacCabe J, Reichenberg A, Zanelli J, Fearon P, Jones PB, Murray RM, Pariante CM, Dazzan P: Is there a link between childhood trauma, cognition, and amygdala and hippocampus volume in first-episode psychosis? Schizophrenia Research 137(1–3):73–79, 2012.CrossRefPubMed Aas M, Navari S, Gibbs A, Mondelli V, Fisher HL, Morgan C, Morgan K, MacCabe J, Reichenberg A, Zanelli J, Fearon P, Jones PB, Murray RM, Pariante CM, Dazzan P: Is there a link between childhood trauma, cognition, and amygdala and hippocampus volume in first-episode psychosis? Schizophrenia Research 137(1–3):73–79, 2012.CrossRefPubMed
37.
Zurück zum Zitat Aas M, Djurovic S, Athanasiu L, Steen NE, Agartz I, Lorentzen S, Sundet K, Andreassen OA, Melle I: Serotonin transporter gene polymorphism, childhood trauma, and cognition in patients with psychotic disorders. Schizophrenia Bulletin 38(1):15–22, 2012.CrossRefPubMed Aas M, Djurovic S, Athanasiu L, Steen NE, Agartz I, Lorentzen S, Sundet K, Andreassen OA, Melle I: Serotonin transporter gene polymorphism, childhood trauma, and cognition in patients with psychotic disorders. Schizophrenia Bulletin 38(1):15–22, 2012.CrossRefPubMed
38.
Zurück zum Zitat Mondelli V, Cattaneo A, Murri MB, Di Forti M, Handley R, Hepgul N, Miorelli A, Navari S, Papadopoulos AS, Aitchison KJ, Morgan C, Murray RM, Dazzan P, Pariante CM: Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: A pathway to smaller hippocampal volume. The Journal of Clinical Psychiatry 72(12):1677–1684, 2011.CrossRefPubMedPubMedCentral Mondelli V, Cattaneo A, Murri MB, Di Forti M, Handley R, Hepgul N, Miorelli A, Navari S, Papadopoulos AS, Aitchison KJ, Morgan C, Murray RM, Dazzan P, Pariante CM: Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: A pathway to smaller hippocampal volume. The Journal of Clinical Psychiatry 72(12):1677–1684, 2011.CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Gatt JM, Nemeroff CB, Dobson-Stone C, Paul RH, Bryant RA, Schofield PR, Gordon E, Kemp AH, Williams LM: Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Molecular Psychiatry 14(7):681–695, 2009.CrossRefPubMed Gatt JM, Nemeroff CB, Dobson-Stone C, Paul RH, Bryant RA, Schofield PR, Gordon E, Kemp AH, Williams LM: Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Molecular Psychiatry 14(7):681–695, 2009.CrossRefPubMed
40.
Zurück zum Zitat Dalvie S, Stein DJ, Koenen K, Cardenas V, Cuzen NL, Ramesar R, Fein G, Brooks SJ: The BDNF p.Val66Met polymorphism, childhood trauma, and brain volumes in adolescents with alcohol abuse. BMC Psychiatry 14:328, 2014.CrossRefPubMedPubMedCentral Dalvie S, Stein DJ, Koenen K, Cardenas V, Cuzen NL, Ramesar R, Fein G, Brooks SJ: The BDNF p.Val66Met polymorphism, childhood trauma, and brain volumes in adolescents with alcohol abuse. BMC Psychiatry 14:328, 2014.CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Aas M, Haukvik UK, Djurovic S, Tesli M, Athanasiu L, Bjella T, Hansson L, Cattaneo A, Agartz I, Andreassen OA, Melle I: Interplay between childhood trauma and BDNF val66met variants on blood BDNF mRNA levels and on hippocampus subfields volumes in schizophrenia spectrum and bipolar disorders. Journal of Psychiatric Research 59:14–21, 2014.CrossRefPubMed Aas M, Haukvik UK, Djurovic S, Tesli M, Athanasiu L, Bjella T, Hansson L, Cattaneo A, Agartz I, Andreassen OA, Melle I: Interplay between childhood trauma and BDNF val66met variants on blood BDNF mRNA levels and on hippocampus subfields volumes in schizophrenia spectrum and bipolar disorders. Journal of Psychiatric Research 59:14–21, 2014.CrossRefPubMed
42.
Zurück zum Zitat Aas M, Haukvik UK, Djurovic S, Bergmann O, Athanasiu L, Tesli MS, Hellvin T, Steen NE, Agartz I, Lorentzen S, Sundet K, Andreassen OA, and Melle I: BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses. Progress in Neuro-Psychopharmacology and Biological Psychiatry 46:181–188, 2013.CrossRefPubMed Aas M, Haukvik UK, Djurovic S, Bergmann O, Athanasiu L, Tesli MS, Hellvin T, Steen NE, Agartz I, Lorentzen S, Sundet K, Andreassen OA, and Melle I: BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses. Progress in Neuro-Psychopharmacology and Biological Psychiatry 46:181–188, 2013.CrossRefPubMed
43.
Zurück zum Zitat Theleritis C, Fisher HL, Shäfer I, Winters L, Stahl D, Morgan C, Dazzan P, Breedvelt J, Sambath I, Vitoratou S, Russo M, Reichenberg A, Falcone MA, Mondelli V, O’Connor J, David A, McGuire P, Pariante C, Di Forti M, Murray RM, Bonaccorso S: Brain derived neurotropic factor (BDNF) is associated with childhood abuse but not cognitive domains in first episode psychosis. Schizophrenia Research 159(1):56–61, 2014.CrossRefPubMed Theleritis C, Fisher HL, Shäfer I, Winters L, Stahl D, Morgan C, Dazzan P, Breedvelt J, Sambath I, Vitoratou S, Russo M, Reichenberg A, Falcone MA, Mondelli V, O’Connor J, David A, McGuire P, Pariante C, Di Forti M, Murray RM, Bonaccorso S: Brain derived neurotropic factor (BDNF) is associated with childhood abuse but not cognitive domains in first episode psychosis. Schizophrenia Research 159(1):56–61, 2014.CrossRefPubMed
44.
Zurück zum Zitat Bortoluzzi A, Salum GA, Blaya C, Silveira PP, Grassi-Oliveira R, da Rosa ED, de Aguiar BW, Stertz L, Bosa VL, Schuch I, Goldani M, Kapczinski F, Leistner-Segal S, Manfro GG: Mineralocorticoid receptor genotype moderates the association between physical neglect and serum BDNF. Journal of Psychiatric Research 59:8–13, 2014.CrossRefPubMed Bortoluzzi A, Salum GA, Blaya C, Silveira PP, Grassi-Oliveira R, da Rosa ED, de Aguiar BW, Stertz L, Bosa VL, Schuch I, Goldani M, Kapczinski F, Leistner-Segal S, Manfro GG: Mineralocorticoid receptor genotype moderates the association between physical neglect and serum BDNF. Journal of Psychiatric Research 59:8–13, 2014.CrossRefPubMed
45.
Zurück zum Zitat Hernaus D, van Winkel R, Gronenschild E, Habets P, Kenis G, Marcelis M, van Os J, Myin-Germeys I, Collip D: Brain-derived neurotrophic factor/FK506-binding protein 5 genotype by childhood trauma interactions do not impact on hippocampal volume and cognitive performance. PLoS One 9(3):e92722, 2014.CrossRefPubMedPubMedCentral Hernaus D, van Winkel R, Gronenschild E, Habets P, Kenis G, Marcelis M, van Os J, Myin-Germeys I, Collip D: Brain-derived neurotrophic factor/FK506-binding protein 5 genotype by childhood trauma interactions do not impact on hippocampal volume and cognitive performance. PLoS One 9(3):e92722, 2014.CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Vrijsen JN, van Oostrom I, Arias-Vásquez A, Franke B, Becker ES, Speckens A: Association between genes, stressful childhood events and processing bias in depression vulnerable individuals. Genes, Brain and Behavior 13(5):508–516, 2014.CrossRef Vrijsen JN, van Oostrom I, Arias-Vásquez A, Franke B, Becker ES, Speckens A: Association between genes, stressful childhood events and processing bias in depression vulnerable individuals. Genes, Brain and Behavior 13(5):508–516, 2014.CrossRef
47.
Zurück zum Zitat Savitz J, van der Merwe L, Stein DJ, Solms M, Ramesar R: Genotype and childhood sexual trauma moderate neurocognitive performance: A possible role for brain-derived neurotrophic factor and apolipoprotein E variants. Biological Psychiatry 62(5):391–399, 2007.CrossRefPubMed Savitz J, van der Merwe L, Stein DJ, Solms M, Ramesar R: Genotype and childhood sexual trauma moderate neurocognitive performance: A possible role for brain-derived neurotrophic factor and apolipoprotein E variants. Biological Psychiatry 62(5):391–399, 2007.CrossRefPubMed
48.
Zurück zum Zitat Roth TL, Lubin FD, Funk AJ, Sweatt JD: Lasting epigenetic influence of early-life adversity on the BDNF gene. Biological Psychiatry 65(9):760–769, 2009.CrossRefPubMedPubMedCentral Roth TL, Lubin FD, Funk AJ, Sweatt JD: Lasting epigenetic influence of early-life adversity on the BDNF gene. Biological Psychiatry 65(9):760–769, 2009.CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Alemany S, Arias B, Aguilera M, Villa H, Moya J, Ibáñez MI, Vossen H, Gastó C, Ortet G, Fañanás L: Childhood abuse, the BDNF-Val66Met polymorphism and adult psychotic-like experiences. The British Journal of Psychiatry 199(1):38–42, 2011.CrossRefPubMed Alemany S, Arias B, Aguilera M, Villa H, Moya J, Ibáñez MI, Vossen H, Gastó C, Ortet G, Fañanás L: Childhood abuse, the BDNF-Val66Met polymorphism and adult psychotic-like experiences. The British Journal of Psychiatry 199(1):38–42, 2011.CrossRefPubMed
Metadaten
Titel
Cognitive Impairment in Schizophrenia: Interplay of BDNF and Childhood Trauma? A Review of Literature
verfasst von
Geetanjali Sahu
Kishor Malavade
Theresa Jacob
Publikationsdatum
24.11.2015
Verlag
Springer US
Erschienen in
Psychiatric Quarterly / Ausgabe 3/2016
Print ISSN: 0033-2720
Elektronische ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-015-9409-8

Weitere Artikel der Ausgabe 3/2016

Psychiatric Quarterly 3/2016 Zur Ausgabe

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.